Genocea Biosciences Inc (GNCAQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,196 | -43,714 | -38,950 | -27,811 | -56,710 |
| Depreciation Amortization | 1,557 | 1,138 | 1,097 | 1,088 | 1,516 |
| Accounts payable and accrued liabilities | -57 | 31 | -1,106 | -2,103 | 491 |
| Other Working Capital | 2,165 | 3,044 | -1,317 | -4,943 | 1,853 |
| Other Operating Activity | -15,839 | -2,150 | 2,542 | -7,466 | 5,251 |
| Operating Cash Flow | $-45,370 | $-41,651 | $-37,734 | $-41,235 | $-47,599 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 35,937 |
| PPE Investments | -3,208 | -2,555 | -1,087 | -131 | -1,028 |
| Investing Cash Flow | $-3,208 | $-2,555 | $-1,087 | $-131 | $34,909 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | N/A | N/A | 592 | N/A |
| Debt Repayment | -15,233 | -134 | -1,919 | -535 | -3,149 |
| Common Stock Issued | 11,567 | 83,982 | 54,820 | 55,525 | 639 |
| Other Financing Activity | -377 | 0 | 0 | -127 | 49 |
| Financing Cash Flow | $5,957 | $83,848 | $52,901 | $55,455 | $-2,461 |
| Beginning Cash Position | 80,400 | 40,758 | 26,678 | 12,589 | 27,740 |
| End Cash Position | 37,779 | 80,400 | 40,758 | 26,678 | 12,589 |
| Net Cash Flow | $-42,621 | $39,642 | $14,080 | $14,089 | $-15,151 |
| Free Cash Flow | |||||
| Operating Cash Flow | -45,370 | -41,651 | -37,734 | -41,235 | -47,599 |
| Capital Expenditure | -3,288 | -2,585 | -1,135 | -241 | -1,178 |
| Free Cash Flow | -48,658 | -44,236 | -38,869 | -41,476 | -48,777 |